Stability and solubility of celecoxib-PVP amorphous dispersions: A molecular perspective

被引:172
|
作者
Gupta, P [1 ]
Kakumanu, VK [1 ]
Bansal, AK [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut Technol Formulat, SAS Nagar 160062, Punjab, India
关键词
celecoxib; characterization; enthalpy relaxation; molecular dispersion; release mechanisms;
D O I
10.1023/B:PHAM.0000045226.42859.b8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of the current study is to evaluate the solubility advantage offered by celecoxib (CEL) amorphous systems and to characterize and correlate the physical and thermodynamic properties of CEL and its amorphous molecular dispersions containing poly-(vinylpyrrolidone) (PVP). Methods. The measurement of crystalline content, glass transition temperatures, and enthalpy relaxation was performed using differential scanning calorimetry. Solubility and dissolutions studies were conducted at 37degreesC to elucidate release mechanisms. Further, the amorphous systems were characterized by polarized light microscopy and X-ray powder diffraction studies. Results. The PVP content has a prominent effect on the stability and solubility profiles of amorphous systems. A dispersion of 20% w/w PVP with CEL resulted in a maxima in terms of solubility enhancement and lowering of relaxation enthalpy. The release of drug from amorphous molecular dispersions was found to be drug-dependent and independent of the carrier. Conclusions. The solubility enhancement and enthalpy relaxation studies with respect to PVP concentration helped in a better prediction of role of carrier and optimization of concentration in the use of solid dispersions or amorphous systems. The drug release mechanism is drug-controlled rather than carrier-controlled.
引用
收藏
页码:1762 / 1769
页数:8
相关论文
共 50 条
  • [21] Phase Behavior of Amorphous Molecular Dispersions I: Determination of the Degree and Mechanism of Solid Solubility
    Madhav Vasanthavada
    Wei-Qin Tong
    Yatindra Joshi
    M. Serpil Kislalioglu
    Pharmaceutical Research, 2004, 21 : 1598 - 1606
  • [22] Phase Behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility
    Vasanthavada, M
    Tong, WQ
    Joshi, Y
    Kislalioglu, MS
    PHARMACEUTICAL RESEARCH, 2004, 21 (09) : 1598 - 1606
  • [23] Molecular Dynamics and Physical Stability of Amorphous Anti-Inflammatory Drug: Celecoxib
    Grzybowska, K.
    Paluch, M.
    Grzybowski, A.
    Wojnarowska, Z.
    Hawelek, L.
    Kolodziejczyk, K.
    Ngai, K. L.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2010, 114 (40): : 12792 - 12801
  • [24] Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine
    Gupta, P
    Bansal, AK
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (02) : 273 - 281
  • [25] Characterization and stability of ternary solid dispersions with PVP and PHPMA
    Al-Obaidi, Hisham
    Ke, Peng
    Brocchini, Steve
    Buckton, Graham
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 419 (1-2) : 20 - 27
  • [26] Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions
    Huang, Siyuan
    Mao, Chen
    Williams, Robert O., III
    Yang, Chia-Yi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (12) : 3549 - 3561
  • [27] Solubility advantage from amorphous etoricoxib solid dispersions
    Dani, Prateek
    Puri, Vibha
    Bansal, A. K.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (01) : 92 - 101
  • [28] Supersaturated amorphous solid dispersions of celecoxib prepared in situ by microwave irradiation
    Holm, Tobias Palle
    Knopp, Matthias Manne
    Berthelsen, Ragna
    Lobmann, Korbinian
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 626
  • [29] Thermal Stability of Amorphous Solid Dispersions
    Jelic, Dijana
    MOLECULES, 2021, 26 (01):
  • [30] Solid dispersions of diflunisal-PVP:: Polymorphic and amorphous states of the drug
    Martínez-Ohárriz, MC
    Rodríguez-Espinosa, C
    Martín, C
    Goñi, MM
    Tros-Ilarduya, MC
    Sánchez, M
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (06) : 717 - 725